CC Tea, an herbal tisane manufactured by Manipur based SuiGeneris Agronomy Private Limited signed a three-year anti-cancer research collaboration to assess the efficacy of CC Tea extract on molecular pathways in lymphocytes and other blood cells of cancer patients of North-East India. The three phased research undertaking will begin with CC Tea extract tested on blood cells taken from cancer patients to concluding with the product being tested on patients directly.
The company recently concluded a 6 months anti-viral and immunomodulatory research with the prestigious Indian Institute of Technology, Guwahati and have found that CC Tea showed high anti-viral activity to the Japanese Encephalitis Virus (JEV) and Newcastle DiseaseVirus (NDV). It also suggests positive innate immune activation in gene analysis.
Ragesh Keisham, Chairman & CEO of SuiGeneris Agronomy Private Limited said, “Over the years, we have received encouraging feedbacks from our users on various health related benefits after prolonged use of CC Tea. A recent Govt. study finds that North East is the cancer capital of India and this research collaboration with Dr.B Barooah Cancer Institute, Guwahati is a proof of our commitment for a relentless fight against Cancer.”
According to the report, Mizoram and Arunachal Pradesh recorded the highest incidence of new cancer cases in the country among females and males respectively.
CC Tea is one of the fastest growing companies in Manipur and is being sold in the North East Region and Pan India through the e-commerce site and through retail channel. The company is in the process of signing up distribution partners across the country.
